ClosedHealth & Human Services
Advancing Sustainable Implementation of Comprehensive HIV/TB Services for Epidemic Control in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGHCDC-RFA-GH21-2155
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $150,000,000 for Year 1, subject to the availability of funds.
For this NOFO, CDC strongly encourages applicants to apply to the Average One Year Award Amount/Approximate Average Award amount of $25,000,000 instead of applying to the full $150,000,000 Approximate Total Fiscal Year Funding amount for Year 1. Applicants should develop a proposal to spend $25,000,000 carrying out activities in 1 sample province in Mozambique. Exact funding amounts and the geographic scope for each award under this NOFO will be determined at the time of award.
This NOFO aims to implement comprehensive and evidence-based HIV and TB prevention, care, support, and treatment interventions in established facilities and in communities in Mozambique. Included is support for the following areas: human resources for health (HRH); gender-based violence (GBV); Care and Treatment (C&T) of people living with HIV (PLHIV) and TB; Cervical Cancer Screening, Prevention and Treatment of Pre-cancerous Lesions (CECAP); Voluntary medical male circumcision (VMMC); Positive Health, Dignity and Prevention (PHDP); health system strengthening; laboratory; Data Quality Assessments (DQAs); Health Communication; and other technical areas that are critical to achieving epidemic control. Recipients will be expected to provide Direct Service Delivery (DSD), technical assistance (TA) and capacity building to host governmental institutions as well as other stakeholders/partners involved in providing HIV and TB services in Mozambique. Implementation will be at national, provincial, district, and sub-district levels. These activities will be implemented in prioritized health facilities located in the following provinces (number of health facilities per province given in parentheses): Maputo City (28), Maputo (57), Gaza (98), Inhambane (49), Zambezia (144), Nampula (59), Cabo Delgado (44). Additional sites may be added based on continued analysis of the HIV burden within Mozambique.
CFDA Number
93.067
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
February 18, 2021
Close Date
April 19, 2021
Posted Date
February 18, 2021
Eligible Applicant Types
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Tags
HHS-CDC-CGHCFDA:93.067Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left